SCHEMBL102599

SCHEMBL102599

CCCCCCCCCCCCN([C]=O)CCCCCCCCCCCC

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 5/20 0.48
TSHR P16473 1/20 0.42
THRB P10828 1/20 0.42
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
ADH1C P00326 2/20 0.38
ADH1A P07327 2/20 0.38
ADH4 P08319 2/20 0.38
S1PR2 O95136 1/20 0.38
S1PR1 P21453 1/20 0.38
S1PR3 Q99500 1/20 0.38
S1PR5 Q9H228 1/20 0.38
EPHX1 P07099 4/20 0.37
ADH1B P00325 1/20 0.37
ADH7 P40394 1/20 0.37
GBA1 P04062 1/20 0.35
GGPS1 O95749 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL270649 1.00 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL95388 1.00 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL5469943 1.00 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL5479568 1.00 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL276847 1.00 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL277586 1.00 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL5480820 1.00 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL11667597 1.00 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL276870 1.00 DNM1 (0.48) DNM1TSHRTHRBCA12CA1
SCHEMBL5477937 1.00 DNM1 (0.48) DNM1TSHRTHRBCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2478981-B1 SILVER-(CONJUGATED COMPOUND) COMPLEX SUMITOMO CHEMICAL CO (JP) 2020-12-23 EP disclosed
US-10696898-B2 Reverse photochromic compound FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2020-06-30 US disclosed
US-9704612-B2 Composition of silver-conjugated compound composite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-07-11 US disclosed
US-9412487-B2 Silver-(conjugated compound) composite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-08-09 US disclosed
EP-2123639-B1 PROCESS FOR PRODUCTION OF 2,3'-BIPYRIDYL-6'-ONE FUJIFILM FINECHEMICALS CO LTD (JP) 2014-03-26 EP disclosed
US-20140001422-A1 COMPOSITION OF SILVER-CONJUGATED COMPOUND COMPOSITE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-01-02 US disclosed
US-8530662-B2 Pyridyltetrahydropyridines and pyridylpiperidines, and method of manufacturing them FUJIFILM FINECHEMICALS CO., LTD (JP) 2013-09-10 US disclosed
EP-2478981-A1 SILVER-(CONJUGATED COMPOUND) COMPLEX Sumitomo Chemical Co., Ltd (JP) 2012-07-25 EP disclosed
US-20120168693-A1 SILVER-(CONJUGATED COMPOUND) COMPOSITE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-05 US disclosed
EP-2426120-A1 Pyridyltetrahydropyridines and pyridylpiperidines, and method of manufacturing them Fujifilm Finechemicals Co., Ltd. (JP) 2012-03-07 EP disclosed
EP-1786780-A1 IMIDAZOLIUM-METHYL SULFITES FOR USE AS STARTING COMPOUNDS FOR PRODUCING IONIC LIQUIDS BASF AKTIENGESELLSCHAFT (DE) 2007-05-23 EP disclosed
US-20070093528-A1 Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them FUJIFILM FINECHEMICALS CO., LTD (JP) 2007-04-26 US disclosed
EP-1757605-A1 CYCLIC AMINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2007-02-28 EP disclosed
US-20070015859-A1 Polyester resin composition containing organic modified layered silicate FUJI PHOTO FILM CO., LTD. 2007-01-18 US disclosed
EP-1657240-A1 PYRIDYLTETRAHYDROPYRIDINES, PYRIDYLPIPERIDINES, AND PROCESS FOR THE PRODUCTION OF BOTH FUJIFILM FINECHEMICALS CO., LTD. (JP) 2006-05-17 EP disclosed
WO-2006021303-A1 IMIDAZOLIUM-METHYL SULFITES FOR USE AS STARTING COMPOUNDS FOR PRODUCING IONIC LIQUIDS BASF AKTIENGESELLSCHAFT (DE) 2006-03-02 WO disclosed
US-20050171355-A1 Pyridine derivative production method SANKIO CHEMICAL CO., LTD. 2005-08-04 US disclosed
EP-1559711-A1 PREPARATION OF PYRIDINE DERIVATIVES USING PYRIMIDINIUM DERIVATIVES AS INTERMEDIATES Sankio Chemical Co., Ltd. (JP) 2005-08-03 EP disclosed
US-5973146-A Process for the preparation of aminated diketobis (aryl or heteroaryl)pyrrolopyrroles and the use thereof as photoconductive substances CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-10-26 US disclosed
EP-0353184-A1 Process for the preparation of aminated diketodi(het)aryl-pyrrolopyrroles and use of the same as photoconducting substances CIBA-GEIGY AG (CH) 1990-01-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10696898-B2 Reverse photochromic compound CRY1, CRY2, C3AR1 DNM1 4351/4885TSHR 1792/4885THRB 2853/4885
US-20050171355-A1 Pyridine derivative production method CPS1, NAT1, ACMSD DNM1 680/4885TSHR 3836/4885THRB 4446/4885
US-20070093528-A1 Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them QDPR, HRH4, HRH2 DNM1 3785/4885TSHR 33/4885THRB 745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.